News

Arcturus Therapeutics Highlights Upcoming Financial Reporting Event

Arcturus Therapeutics Highlights Upcoming Financial Reporting Event

Arcturus Therapeutics to Reveal Third Quarter Results

Arcturus Therapeutics Holdings Inc. (“Arcturus”, Nasdaq: ARCT) is preparing to announce its financial results for the third quarter. This eagerly awaited conference will take place shortly after the market closes, on November 7, 2024. Investors and stakeholders are encouraged to tune in as the company shares its latest developments.

What to Expect from the Upcoming Call

The conference call, scheduled for 4:30 pm Eastern Time, will provide an in-depth look at the company’s financial performance for the quarter that ended in September. Participants will gain insight into Arcturus’ progress in developing cutting-edge messenger RNA (mRNA) vaccines and therapeutics that address significant healthcare needs.

Engagement Opportunities for Stakeholders

As part of the upcoming event, Arcturus invites everyone interested in the company's vision and results to join the conference call. To participate, individuals can dial:

  • Domestic: 1-800-274-8461
  • International: 1-203-518-9814
  • Conference ID: ARCTURUS

About Arcturus and Its Innovations

Founded in 2013 and headquartered in San Diego, California, Arcturus Therapeutics has quickly established itself as a leader in mRNA technology. The company is renowned for its innovative approaches to developing vaccines and treatments tailored to combat infectious diseases as well as addressing unmet medical needs within rare liver and respiratory diseases.

Key Technologies Driving Arcturus

Arcturus leverages several advanced technologies to maintain its competitive edge:

  • LUNAR® Technology: This lipid-mediated delivery system significantly enhances the efficacy of mRNA vaccines.
  • STARR® mRNA Technology: A game-changing method that enables self-amplifying mRNA for improved therapeutic outcomes.
  • Manufacturing Expertise: With in-house capabilities, Arcturus ensures the highest quality in drug production, allowing rapid rollout of vaccines.

Notable Achievements in mRNA Development

Arcturus is proud to have developed KOSTAIVE, the world's first approved self-amplifying mRNA COVID vaccine. This milestone reflects the company’s commitment to innovation and improving public health through advanced technology. Collaborations with partners such as CSL Seqirus highlight Arcturus’ ongoing efforts to expand the availability of effective mRNA vaccines.

Pipeline of Promising Therapeutics

The company's diverse pipeline focuses on several mRNA therapeutic candidates that aim to address serious conditions such as ornithine transcarbamylase (OTC) deficiency and cystic fibrosis (CF). In addition, Arcturus has strategic partnerships to enhance its mRNA vaccine programs targeting SARS-CoV-2 and influenza. These initiatives showcase the company’s dedication to contributing to improved healthcare solutions worldwide.

Extensive Patent Portfolio

Arcturus has established a robust intellectual property foundation, with over 400 patents and patent applications, protecting its cutting-edge technologies globally. This extensive portfolio reinforces the company’s position as a recognized leader in the rapidly growing field of RNA therapeutics.

Stay Connected with Arcturus

For those interested in keeping up with the latest developments and achievements from Arcturus, join the community through their social media platforms. Engage with us on Twitter and LinkedIn to receive real-time updates and insights into how we're transforming the landscape of mRNA therapeutics.

Frequently Asked Questions

When will Arcturus Therapeutics report their financial results?

Arcturus Therapeutics is set to report its financial results for the third quarter on November 7, 2024.

How can I participate in the Arcturus conference call?

Interested parties can dial either 1-800-274-8461 for domestic calls or 1-203-518-9814 for international calls using Conference ID: ARCTURUS.

What technologies are vital to Arcturus' operations?

Arcturus utilizes LUNAR® Technology, STARR® mRNA Technology, and boasts manufacturing expertise for its innovative mRNA products.

What is Arcturus’ notable recent achievement?

Arcturus developed KOSTAIVE, the first self-amplifying mRNA COVID vaccine approved globally, showcasing their innovative capabilities.

How does Arcturus ensure its competitive advantage?

With an extensive patent portfolio of over 400 patents and applications, Arcturus safeguards its innovations, ensuring its position in the RNA therapeutics market.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 248

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 348

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 90

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 488

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 389

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Energy Management with ETB Controller from Energy Toolbase

Updated Category News Views 72

Energy Toolbase Reveals New Branding for Energy Management System Energy Toolbase has made a significant leap in the energy management sector by rebranding its energy storage control software, Acumen EMS™, to ETB Controller. This transformation marks a pivotal moment for the company as they strive to clarify the product's purpose and enhance user understanding. The ETB...

Continue Reading
FICO Achieves Silver Recognition in Analytics at 2024 IT Awards

Updated Category News Views 37

FICO Receives Silver Award for Analytics in 2024 IT Awards In a notable recognition of excellence, global analytics software leader FICO has earned the Silver Award in the Analytics category at the prestigious IT Awards for this year. Organized by Vogel IT-Media, these awards celebrate remarkable achievements and innovations within the IT sector, reflecting the industry's...

Continue Reading
Opera Limited Announces $0.40 Cash Dividend for Shareholders

Updated Category News Views 124

Opera Limited Announces Cash Dividend Opera Limited (NASDAQ: OPRA), a prominent developer in the browser market, has recently shared exciting news regarding its dividend program. The company’s Board of Directors has approved a semi-annual cash dividend of $0.40 per share. This dividend will be available to shareholders holding the company’s ordinary shares and...

Continue Reading
Revolutionizing IT Operations: JetPatch Unveils Version 5.0

Updated Category News Views 162

Revolutionizing IT Operations: JetPatch Unveils Version 5.0 New Capabilities Supercharge Patch Management and Streamline Enterprise Efficiency JetPatch, a leading innovator in enterprise IT operations, has revealed its most significant software release to date, which marks a major step forward in how organizations manage their servers, endpoints, and agents throughout...

Continue Reading
Revolutionizing Customer Billing: Ericsson and Wipro's Success

Updated Category News Views 97

Transformed Billing Experience for Odido Customers Ericsson (NASDAQ: ERIC) and Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) have successfully reshaped the billing landscape for Odido's mobile customers in the Netherlands. By adopting the cloud-native Ericsson Billing platform, hosted on Amazon Web Services (AWS), Odido can now offer cutting-edge 5G services along...

Continue Reading